Your browser doesn't support javascript.
loading
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
Jaitner, Stefanie; Pretzsch, Elise; Neumann, Jens; Schäffauer, Achim; Schiemann, Matthias; Angele, Martin; Kumbrink, Jörg; Schwitalla, Sarah; Greten, Florian R; Brandl, Lydia; Klauschen, Frederick; Horst, David; Kirchner, Thomas; Jung, Andreas.
Afiliación
  • Jaitner S; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Pretzsch E; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Neumann J; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany.
  • Schäffauer A; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Schiemann M; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany.
  • Angele M; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Kumbrink J; Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany.
  • Schwitalla S; Clinical Cooperation Group Immune Monitoring, Helmholtz Center Munich (Neuherberg) and Technische Universität München, Munich, Germany.
  • Greten FR; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Brandl L; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Klauschen F; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany.
  • Horst D; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.
  • Kirchner T; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany.
  • Jung A; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.
J Pathol Clin Res ; 9(1): 73-85, 2023 01.
Article en En | MEDLINE | ID: mdl-36349502
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígenos de Diferenciación / Factor Estimulante de Colonias de Granulocitos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Pathol Clin Res Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígenos de Diferenciación / Factor Estimulante de Colonias de Granulocitos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Pathol Clin Res Año: 2023 Tipo del documento: Article País de afiliación: Alemania